News Focus
News Focus
Followers 212
Posts 6120
Boards Moderated 1
Alias Born 01/07/2015

Re: finesand post# 39812

Saturday, 04/13/2019 5:48:52 AM

Saturday, April 13, 2019 5:48:52 AM

Post# of 236717
They only listed one author per paper, he is referenced (et al) in this one at least. I recognize the paper, could be others.

Velasco-Velazquez, M. et al. CCR5 antagonist blocks metastasis of basal breast cancer cells. Cancer Res. 72, 3839–3850 (2012).

http://cancerres.aacrjournals.org/content/72/15/3839

I think negotiations are still ongoing, but we have reached a point without a finalized deal, they need to start looking at a backup plan. My guess on the TNBC delay, legalistically issues starting the trial, including getting all 5 sites onboard. If you look at any other trial, just for example with the pi alone, it usually takes several months to start.

My opinion also, but the TNBC trial is a high priority, second only to finishing the BLA and they start it soon, the 10Q was updated to starting Q2. It is a small trial, costing a few million, not the 25 million the mono trial has costed. Good early results should pay massive dividends giving them much larger leverage in negotiations, nee potential partners, etc.

I agree on the money. It is frustrating knowing that is really the main item holding this stock back. They have been chipping away at it though, each month, the amount needed until approval gets smaller, eventually we will break free.

Also, we are due an update, especially with TNBC trial. I’m assuming they have leveraged that info for the latest offering as usual, but I’m tired of speculating now for three months and feel all shareholders deserve a full update, be it good or bad.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News